NVIV ROE (Return on Equity)
As of 2025-05-26, the ROE (Return on Equity) of InVivo Therapeutics Holdings Corp (NVIV) is -66.6%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
NVIV ROE (Return on Equity) - Historical Value
| Date | Value |
|---|---|
| 2022-12-31 | -66.6% |
| 2021-12-31 | -54.6% |
| 2020-12-31 | -47.3% |
| 2019-12-31 | -212% |
| 2018-12-31 | -145.4% |
| 2017-12-31 | -264.6% |
| 2016-12-31 | -81% |
| 2015-12-31 | -196.8% |
| 2014-12-31 | -310% |
| 2013-12-31 | -300.7% |
NVIV ROE (Return on Equity) - Peers Comparison